Adherence to the Mediterranean Diet Improved Clinical Scores and Inflammatory Markers in Children with Active Inflammatory Bowel Disease: A Randomized Trial

Bibliographic Information
Authors: El Amrousy D.; Elashry H.; Salamah A.; Maher S.; Abd-Elsalam S.M.; Hasan S.
Journal: Journal of Inflammation Research
Publisher: Dove Medical Press Ltd
Publication Date: March 2022
Volume / Issue: Volume 15
Pages: 2075–2086
ISSN: 11787031
DOI: 10.2147/JIR.S349502
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
El Amrousy D., Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt; Elashry H., Tropical Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt; Salamah A., Pediatric Department, Kafr Elsheikh University, Kafr Elsheikh, Egypt; Maher S., Theodor Bilharz Research Institute, Cairo, Egypt; Abd-Elsalam S.M., Tropical Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt; Hasan S., Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt
Abstract
Objective: The Mediterranean diet (MD) is a well-known style of diet that is full of antioxidants and may have anti-inflammatory effects. We evaluated the safety, tolerability, and effects of adherence to MD on disease activity and inflammatory markers in children and adolescents with active inflammatory bowel disease (IBD). Methods: This prospective, randomized study included 100 IBD patients aged twelve to eighteen years with mild to moderate disease activity (PCDAI score 10–45 or PUCAI 10–64). The included patients were divided into two groups of 50 patients each. Group I (26 patients with active CD and 24 patients with active UC) received MD with good adherence over 12 weeks with a KIDMED 8-point score, and group II (28 patients with active CD and 22 patients with active UC) received their usual diet with a KIDMED score ≤7 points. Patients in both groups received treatment similar for IBD activity. Results: Clinical remission was achieved in most of the patients after 12 weeks of treatment. Patients in the first group (adhering to an MD) showed a significant decrease in both clinical scores (PCDAI and PUCAI) and most inflammatory markers (CRP, calprotectin, TNF-α, IL17., IL 12 and IL13) compared to patients in their normal group, with earlier improvement in both PCDAI and CRP. Conclusion: Adherence to the MD improves clinical scores and inflammatory markers in children and adolescents with mild-moderate active IBD. © 2022.
Keywords
children; cytokines; inflammatory bowel disease; inflammatory markers; Mediterranean diet; C reactive protein; calgranulin; cytokine; interleukin 12; interleukin 13; interleukin 17; tumor necrosis factor; adolescent; adult; Article; case control study; child; Child and Adolescent Mediterranean Diet Quality Index; clinical outcome; controlled study; Crohn disease; Crohn Disease Activity Index; dietary compliance; digestive system disease assessment; disease activity; female; human; juvenile Ulcerative Colitis Activity Index; major clinical study; male; nutritional assessment; parallel design; patient safety; prospective study; randomized controlled trial; remission; ulcerative colitis
Citation Information
Scopus Citations: 66
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
